LIVE · PREMARKET
VOL. VII · ISSUE 114TUE · JUN 9 · 2026Sign in
The Green Brief
Daily Fact

💊Epidiolex, the first FDA-approved cannabis-derived drug, treats severe childhood epilepsy and generated $800M+ in annual revenue.— Jazz Pharmaceuticals

The Green Brief
Independent reporting and market intelligence for the cannabis economy. Read each morning by operators, analysts, and allocators.
cannanews.io · est. 2021
Sections
Markets
Policy
Science
Culture
States
Strategy
Products
Daily Brief
Green Cultivar
Markets
Interactive Charts
Archive
Company
About
Contact
Privacy